Skip to main content
Sarah Matyko, PhDEnterprise Health Product & Strategy Executive

Ideas & Speaking

The next era of health will not be defined by more interventions.

It will be shaped by better systems that make credible care easier to choose, use, measure, and sustain.

My work and speaking focus on the gap between what health science makes possible and what people and organizations can carry into real life.

Four territories

01

From evidence to adoption

Scientific validity tells us whether an intervention can work under defined conditions. It does not tell us whether people will understand it, trust it, choose it, or stay with it.

Adoption is not a communications problem placed at the end of product development. It is a design requirement from the beginning. The evidence, behavioral target, value proposition, experience, and delivery model must agree on what the person is being asked to do and why it is worth doing.

02

Behavior as product infrastructure

Behavior is not a soft layer added after the technology is built. It is part of the product architecture.

Identity, context, readiness, effort, social expectations, and timing shape whether a health product becomes useful in daily life. When those forces are ignored, organizations often compensate with more reminders, more content, or more incentives. When they are designed into the system, the next healthy action becomes easier to see and take.

03

Personalization with purpose

More data can improve prediction while leaving the human decision untouched.

Purposeful personalization begins with the behavior or outcome that matters. It then asks what context is required to make the next action relevant, what the model can responsibly infer, what the person should understand, and how the organization will learn whether the intervention helped.

The standard for AI in health should not be novelty or activity. It should be a better decision, a more useful experience, and a measurable improvement in what follows.

04

Prevention as an enterprise system

Health unfolds across time, settings, relationships, and repeated choices. A single intervention can be valuable, but it cannot carry prevention alone.

The enterprise product is the connected system around it: the journey, access points, human support, data, handoffs, operating standards, feedback, and measurement. Prevention becomes scalable when the system makes the right action easier for the individual and more reliable for the organization.

Selected perspectives

Evidence Is the Starting Line

The central question in health innovation is often framed too narrowly: Does it work?

The better question is: Under what conditions does it work, for whom, and can we reproduce those conditions outside the study or pilot?

Evidence defines the credible possibility. Product and experience translate it into use. Operations make it repeatable. Measurement tells us whether the intended value survived the transition. Scientific rigor is not weakened by these questions. It becomes more consequential.

Engagement Is a Mechanism, Not an Outcome

Logins, clicks, visits, and completed activities can be useful measures of exposure and use. They are not, by themselves, evidence of better health or enterprise value.

Engagement matters when it sits inside a clear pathway: a person engages, the engagement changes a relevant behavior or care decision, that change contributes to an outcome, and the outcome matters to both the person and the organization.

Measure engagement. Just do not stop there.

Personalization Requires Context, Not More Data

A health platform can know a great deal about someone and still recommend the wrong next step.

Context explains what data alone cannot: whether the person is ready, what competing demands are present, which identity is active, what support is available, and what form of effort is realistic now.

The goal is not to create the most personalized message. It is to make a better decision about what help is useful, for this person, in this moment.

The Best Health Product Is a System, Not an Intervention

An intervention is a moment. Health is longitudinal.

The strongest products connect the moment to what came before and what should happen next. They link evidence to a journey, the journey to human support and operations, and use to meaningful measurement.

This is why strong interventions can underperform inside weak systems, while thoughtful systems can make simple interventions far more valuable.

What Luxury Can Teach Healthcare About Adoption

Luxury is often mistaken for excess. Its more useful lesson is attention.

Exceptional experiences reduce avoidable effort, anticipate needs, preserve dignity, and make the person feel understood. These are not decorative qualities in health. They influence trust, participation, and continued use.

Healthcare should not imitate hospitality. It should study how carefully designed environments make complex experiences feel clear, personal, and worth returning to.

Selected appearances

HLTH 2025 Women's Leadership Event

Topic: Behavioral Science Meets Wellness

A discussion of how behavioral science can help health and wellness experiences move from intention to meaningful use.

Behavioral Product Summit 2024

Topic: From AI to Authentic Wellness: Humanizing Predictive Technology

How predictive technology can support better health decisions without losing transparency, context, or the human experience.

Healthcare CX Masterclass with Matthew Luhn

Role: Storyteller and co-facilitator

Using narrative to help leaders make healthcare strategy easier to understand, remember, and act on.

HR Gazette

Feature: Digital Transformation and Evidence-Based Engagement

An executive conversation about translating evidence and behavioral science into digital health experiences that create measurable value.

Read the featureopens in a new tab

Speaking topics

Making evidence usable

The product strategy of real-world health adoption

Why credible interventions fail in practice and how leaders can connect evidence, behavior, experience, and operations from the start.

AI, behavior, and responsible personalization

How to define a meaningful behavioral target, use context responsibly, and judge AI by the decision and outcome it improves.

Why engagement is not the outcome

How to build a measurement chain from exposure and use to behavior, health outcomes, retention, cost, and enterprise value.

Designing preventive health as an enterprise system

How product, experience, human support, data, governance, and economics must work together to make prevention scalable.

Bring a more useful question to the room.

I speak with executive teams, industry audiences, and cross-functional leaders who want to examine health innovation with greater rigor and practical relevance.

Invite Sarah to speakDiscuss an advisory need